New targeted therapy finds and eliminates deadly leukaemia stem cells

New research describes a molecular tool that shows great promise as a therapeutic for human acute myeloid leukaemia (AML), a notoriously treatment-resistant blood cancer. The study, published by Cell Press in the 2nd July issue of the journal Cell Stem Cell, describes exciting preclinical studies in which a new therapeutic approach selectively attacks human cancer cells grown in the lab and in animal models of leukaemia...

Read the whole article on

More from